176 related articles for article (PubMed ID: 27022239)
1. An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects.
Borchert M; Bruce S; Wirta D; Yoelin SG; Lee S; Mao C; VanDenburgh A
Clin Ophthalmol; 2016; 10():419-29. PubMed ID: 27022239
[TBL] [Abstract][Full Text] [Related]
2. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
[TBL] [Abstract][Full Text] [Related]
3. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects.
Wirta D; Baumann L; Bruce S; Ahluwalia G; Weng E; Daniels S
J Clin Aesthet Dermatol; 2015 Apr; 8(4):11-20. PubMed ID: 26060513
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
Ahluwalia GS
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
Glaser DA; Hossain P; Perkins W; Griffiths T; Ahluwalia G; Weng E; Beddingfield FC
Br J Dermatol; 2015; 172(5):1384-94. PubMed ID: 25296533
[TBL] [Abstract][Full Text] [Related]
7. Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical Trials.
Wirta D; Pariser DM; Yoelin SG; Arase S; McMichael A; Weng E; Mao C; Demos G; Vandenburgh A
J Clin Aesthet Dermatol; 2015 Jul; 8(7):17-29. PubMed ID: 26203317
[TBL] [Abstract][Full Text] [Related]
8. Bimatoprost in the treatment of eyelash hypotrichosis.
Law SK
Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
[TBL] [Abstract][Full Text] [Related]
10. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
Fagien S
Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
[TBL] [Abstract][Full Text] [Related]
11. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
Ricar J; Cetkovska P; Hordinsky M; Ricarova R
Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027
[TBL] [Abstract][Full Text] [Related]
12. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
Fagien S
Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
[TBL] [Abstract][Full Text] [Related]
13. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
14. The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: an analysis of efficacy and safety.
Morris CL; Stinnett S; Woodward J
Int J Trichology; 2011 Jul; 3(2):84-91. PubMed ID: 22223967
[TBL] [Abstract][Full Text] [Related]
15. Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study.
Beer KR; Julius H; Dunn M; Wilson F
Dermatol Surg; 2013 Jul; 39(7):1079-87. PubMed ID: 23617229
[TBL] [Abstract][Full Text] [Related]
16. Bimatoprost in the treatment of eyelash universalis alopecia areata.
Vila TO; Camacho Martinez FM
Int J Trichology; 2010 Jul; 2(2):86-8. PubMed ID: 21712909
[TBL] [Abstract][Full Text] [Related]
17. Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis.
Carruthers J; Beer K; Carruthers A; Coleman WP; Draelos ZD; Jones D; Goldman MP; Pucci ML; VanDenburgh A; Weng E; Whitcup SM
Dermatol Surg; 2016 May; 42(5):608-17. PubMed ID: 27124878
[TBL] [Abstract][Full Text] [Related]
18. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.
Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W
Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis: A Randomized, Double-Blind, Vehicle-Controlled Study.
Suchonwanit P; Chanasumon N; Sriphojanart T
Dermatol Surg; 2019 Dec; 45(12):1549-1556. PubMed ID: 30913051
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis.
Chanasumon N; Sriphojanart T; Suchonwanit P
Drug Des Devel Ther; 2018; 12():365-372. PubMed ID: 29503529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
